HIGHLIGHTS
- who: Nikita Dutta and collaborators from the Roche (Switzerland), Switzerland Yat-sen University, China have published the article: Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer, in the Journal: (JOURNAL)
- what: In the study , the effects of PD-1 blockade on the tumor biology/ genetics and the immune system in the same patient were explored based on the hypothesis that a combination of immunological and genetic biomarkers can improve the specificity of predicting clinical response to PD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.